| Expression pattern: |
UP |
| Associated gene: |
CA19-9 |
| Associated microRNA: |
- |
| Biological function: |
Potential biomarker indicative of tumor invasion capacity and metastatic potential in pancreatic cancer; associated with venous invasion, lymphatic invasion, and metastasis. |
| Molecular mechanism: |
- |
| Biological pathway or process: |
metastasis (other); invasion (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Sanger Sequencing; divergent primers PCR; Back-Splice Junction PCR / divergent primers PCR; Clinical Sample Validation; ROC Analysis |
| Clinical significance: |
circ-LDLRAD3 may be a biomarker in the diagnosis of pancreatic cancer; ROC AUC 0.67 alone and 0.87 combined with CA19-9. |
| Description: |
circ-LDLRAD3 (hsa_circ_0006988) is up-regulated in pancreatic cancer tissues, plasma, and pancreatic cancer cell lines. It is associated with invasive/metastatic clinicopathological features and shows diagnostic utility, especially when combined with CA19-9. |
| Confidence score: |
0.6291 |